Dana Carroll
Affiliations: | Biochemistry | University of Utah, Salt Lake City, UT |
Area:
Biochemistry, Molecular BiologyGoogle:
"Dana Carroll"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ignacio Tinoco | grad student | ||
| Donald D. Brown | post-doc | University of Utah |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Carroll D. (2019) Collateral damage: benchmarking off-target effects in genome editing. Genome Biology. 20: 114 |
| Yarrington RM, Verma S, Schwartz S, et al. (2018) Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proceedings of the National Academy of Sciences of the United States of America |
| Carroll D. (2018) p53 Throws CRISPR a Curve. Trends in Pharmacological Sciences |
| Sarno R, Vicq Y, Uematsu N, et al. (2017) Programming sites of meiotic crossovers using Spo11 fusion proteins. Nucleic Acids Research |
| DeWitt M, Corn JE, Carroll D. (2017) Genome editing via delivery of Cas9 ribonucleoprotein. Methods (San Diego, Calif.) |
| Carroll D. (2016) Genome editing: progress and challenges for medical applications. Genome Medicine. 8: 120 |
| DeWitt MA, Magis W, Bray NL, et al. (2016) Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Science Translational Medicine. 8: 360ra134 |
| Carroll D. (2016) A Perspective on the State of Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 412-3 |
| Chandrasegaran S, Carroll D. (2015) Origins of Programmable Nucleases for Genome Engineering. Journal of Molecular Biology |
| Corrigan-Curay J, O'Reilly M, Kohn DB, et al. (2015) Genome editing technologies: defining a path to clinic. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 796-806 |